{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:40:17Z","timestamp":1777473617848,"version":"3.51.4"},"reference-count":35,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Platelet transfusion is a necessary life-sustaining therapy for extreme thrombocytopenia from multiple etiologies. However, refractoriness develops in some patients such that transfused platelets are rapidly cleared and refractory patients are at risk for catastrophic hemorrhage. One cause of refractoriness is humoral immunization to major histocompatibility complex I (MHC-I) alloantigens. However, \u223c50% of patients with alloantibodies to MHC-I do not become refractory. The factors that determine whether an alloimmunized patient is refractory remain undefined. Both mice and humans encode 4 distinct immunoglobulin G (IgG) subclasses, each with different effector function characteristics. In this article, we forward the hypothesis that IgG subclass composition of alloantisera affects refractoriness. A novel panel of mice was generated with mutated effector function for different murine IgG subclasses. Elimination of effector function of IgG2c (but not IgG1 or IgG2b) eliminated the ability of alloantisera to clear transfused platelets. Together, these data demonstrate the differential platelet\u2013clearing activity of distinct IgG subclasses in vivo and support the hypothesis that differences in IgG subclass affect whether alloimmunization results in refractoriness to platelet transfusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017730","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:09:08Z","timestamp":1770062948000},"page":"2592-2598","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Alloantibody IgG subclasses have differential activity in clearing transfused platelets in mice"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7055-5879","authenticated-orcid":false,"given":"Elizabeth L.","family":"Frost","sequence":"first","affiliation":[{"name":"1Beirne Carter Immunology Center, University of Virginia, Charlottesville VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-4932","authenticated-orcid":false,"given":"Arijita","family":"Jash","sequence":"additional","affiliation":[{"name":"1Beirne Carter Immunology Center, University of Virginia, Charlottesville VA"},{"name":"2Department of Pathology, University of Virginia, Charlottesville VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9003-6415","authenticated-orcid":false,"given":"Ariel M.","family":"Hay","sequence":"additional","affiliation":[{"name":"1Beirne Carter Immunology Center, University of Virginia, Charlottesville VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9586-3655","authenticated-orcid":false,"given":"Robert","family":"Brink","sequence":"additional","affiliation":[{"name":"3Garvan Institute of Medical Research, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2258-6490","authenticated-orcid":false,"given":"Angelo","family":"D\u2019Alessandro","sequence":"additional","affiliation":[{"name":"4Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-2520","authenticated-orcid":false,"given":"Monika","family":"Dzieciatkowska","sequence":"additional","affiliation":[{"name":"4Department of Biochemistry and Molecular Genetics, University of Colorado, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1063-4010","authenticated-orcid":false,"given":"James C.","family":"Zimring","sequence":"additional","affiliation":[{"name":"1Beirne Carter Immunology Center, University of Virginia, Charlottesville VA"},{"name":"2Department of Pathology, University of Virginia, Charlottesville VA"},{"name":"5Canadian Blood Services, Ottowa, Canada"},{"name":"6University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"3","key":"2026042809470974400_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness--practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"issue":"4","key":"2026042809470974400_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5858\/arpa.2023-0484-RA","article-title":"Advances in human leukocyte antigen testing technologies and management strategies for platelet transfusion refractoriness","volume":"149","author":"Sullivan","year":"2025","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"2026042809470974400_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tmrv.2020.09.002","article-title":"Non-alloimmune mechanisms of thrombocytopenia and refractoriness to platelet transfusion","volume":"34","author":"Belizaire","year":"2020","journal-title":"Transfus Med Rev"},{"issue":"10","key":"2026042809470974400_bib4","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2026042809470974400_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/trf.13270","article-title":"Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions","volume":"56","author":"Waterman","year":"2016","journal-title":"Transfusion"},{"issue":"9","key":"2026042809470974400_bib6","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/j.1537-2995.2008.01791.x","article-title":"Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells","volume":"48","author":"Aslam","year":"2008","journal-title":"Transfusion"},{"issue":"8","key":"2026042809470974400_bib7","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1182\/blood.V88.8.2959.bloodjournal8882959","article-title":"Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase","volume":"88","author":"Bang","year":"1996","journal-title":"Blood"},{"issue":"5","key":"2026042809470974400_bib8","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood.V95.5.1735.005k47_1735_1742","article-title":"Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens","volume":"95","author":"Bang","year":"2000","journal-title":"Blood"},{"issue":"1","key":"2026042809470974400_bib9","first-page":"84","article-title":"Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension","volume":"9","author":"Claas","year":"1981","journal-title":"Exp Hematol"},{"issue":"11","key":"2026042809470974400_bib10","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1182\/blood.V80.11.2931.2931","article-title":"Effects of leukocyte depletion and UVB irradiation on alloantigenicity of major histocompatibility complex antigens in platelet concentrates: a comparative study","volume":"80","author":"Kao","year":"1992","journal-title":"Blood"},{"issue":"4","key":"2026042809470974400_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1399-0039.2012.01852.x","article-title":"HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management","volume":"79","author":"Pavenski","year":"2012","journal-title":"Tissue Antigens"},{"issue":"1","key":"2026042809470974400_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2249.1990.tb05411.x","article-title":"Activation of lymphocytes after platelet allotransfusion possessing only class I MHC product","volume":"82","author":"Pocsik","year":"1990","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"2026042809470974400_bib13","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1537-2995.2004.04197.x","article-title":"Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype","volume":"44","author":"Sayeh","year":"2004","journal-title":"Transfusion"},{"issue":"7","key":"2026042809470974400_bib14","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1182\/blood-2003-10-3552","article-title":"IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells","volume":"103","author":"Sayeh","year":"2004","journal-title":"Blood"},{"issue":"2","key":"2026042809470974400_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.V93.2.713","article-title":"Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity","volume":"93","author":"Semple","year":"1999","journal-title":"Blood"},{"issue":"2","key":"2026042809470974400_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1182\/blood.V86.2.805.bloodjournal862805","article-title":"Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation","volume":"86","author":"Semple","year":"1995","journal-title":"Blood"},{"issue":"26","key":"2026042809470974400_bib17","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","author":"Trial to Reduce Alloimmunization to Platelets Study Group","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"2026042809470974400_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3324\/haematol.2018.201665","article-title":"Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets","volume":"104","author":"Rijkers","year":"2019","journal-title":"Haematologica"},{"issue":"10","key":"2026042809470974400_bib19","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.3324\/haematol.2021.280493","article-title":"Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets","volume":"107","author":"Van Osch","year":"2022","journal-title":"Haematologica"},{"issue":"3","key":"2026042809470974400_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bjh.16385","article-title":"A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo-immunized patients","volume":"189","author":"Vo","year":"2020","journal-title":"Br J Haematol"},{"issue":"6","key":"2026042809470974400_bib21","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/trf.13598","article-title":"C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants","volume":"56","author":"Jackman","year":"2016","journal-title":"Transfusion"},{"issue":"3","key":"2026042809470974400_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/10245332.2017.1377902","article-title":"FC gamma receptor polymorphisms in patients with immune thrombocytopenia","volume":"23","author":"Pavkovic","year":"2018","journal-title":"Hematology"},{"issue":"8","key":"2026042809470974400_bib23","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/jth.14892","article-title":"The association and functional relevance of genetic variation in low-to-medium-affinity Fc-gamma receptors with clinical platelet transfusion refractoriness","volume":"18","author":"Nagelkerke","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026042809470974400_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0037-1613771","article-title":"The effect of monoclonal anti-human-platelet antibodies on platelet kinetics in a baboon model: IgG subclass dependency","volume":"83","author":"Coetzee","year":"2000","journal-title":"Thromb Haemost"},{"issue":"2","key":"2026042809470974400_bib25","first-page":"535","article-title":"Anti-HLA class I IgG subclasses skew platelet activation mechanisms in transfusion refractoriness","volume":"111","author":"Couvidou","year":"2026","journal-title":"Haematologica"},{"issue":"10","key":"2026042809470974400_bib26","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/00007890-200011270-00020","article-title":"Heterogeneity of T cell clones specific for a single indirect alloantigenic epitope (I-Ab\/H-2Kd54-68) that mediate transplant rejection","volume":"70","author":"Honjo","year":"2000","journal-title":"Transplantation"},{"issue":"1","key":"2026042809470974400_bib27","first-page":"50","article-title":"Hypoxic storage of murine red blood cells improves energy metabolism and post-transfusion recoveries","volume":"21","author":"Hay","year":"2023","journal-title":"Blood Transfus"},{"issue":"11","key":"2026042809470974400_bib28","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1172\/JCI138136","article-title":"Complement activation on endothelium initiates antibody-mediated acute lung injury","volume":"130","author":"Cleary","year":"2020","journal-title":"J Clin Invest"},{"issue":"8","key":"2026042809470974400_bib29","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/nprot.2014.134","article-title":"Generating genetically modified mice using CRISPR\/Cas-mediated genome engineering","volume":"9","author":"Yang","year":"2014","journal-title":"Nat Protoc"},{"issue":"2","key":"2026042809470974400_bib30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/trf.15109","article-title":"Alloimmunogenicity of an isolated MHC allele is affected by the context of MHC mismatch in a murine model","volume":"59","author":"Hudson","year":"2019","journal-title":"Transfusion"},{"issue":"9","key":"2026042809470974400_bib31","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.4049\/jimmunol.181.9.6664","article-title":"Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions","volume":"181","author":"Baudino","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"2026042809470974400_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: a novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"key":"2026042809470974400_bib33","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3389\/fimmu.2020.01516","article-title":"IgG subclass determines suppression versus enhancement of humoral alloimmunity to Kell RBC antigens in mice","volume":"11","author":"Shinde","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"2026042809470974400_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1423-0410.1997.00045.x","article-title":"In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D","volume":"72","author":"Kumpel","year":"1997","journal-title":"Vox Sang"},{"issue":"2","key":"2026042809470974400_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/trf.12921","article-title":"Methods for the selection of platelet products for alloimmune-refractory patients","volume":"55","author":"Kopko","year":"2015","journal-title":"Transfusion"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2592\/2513781\/blooda_adv-2025-017730-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2592\/2513781\/blooda_adv-2025-017730-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:47:17Z","timestamp":1777384037000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/8\/2592\/566384\/Alloantibody-IgG-subclasses-have-differential"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017730","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,28]]},"published":{"date-parts":[[2026,4,15]]}}}